Sheba Medical Center Initiates Ivermectin Study in Pursuit to Investigate Economic & Available COVID-19 Therapy

The top hospital in Israel, and the 9th worldwide, launched an Ivermectin clinical trial targeting COVID-19 patients. The elite Israeli center led by Professor Eli Schwartz seeks to show the world the potential for this economic and available FDA-approved drug. A...

Redhill Biopharma’s Opaganib Shows Promise Among 6 Hospitalized COVID-19 Patients in Israel via Compassionate Use Program

RedHill Biopharma Ltd (RDHL), a specialty biopharmaceutical company, reports that all six hospitalized patients with confirmed SARS-CoV-2 infection (the cause of COVID-19) that received their experimental drug opaganib (Yeliva®) demonstrated measurable clinical...

Pin It on Pinterest